Clinical Trials

Sponsor: NRG

Sponsor Study ID: GU010

Study Title: Parallel Phase III Randomized Trials of Genomic Risk Stratified Unfavorable Intermediate Risk Prostate Cancer: De Intensification and Intensification Clinical Trial Evaluation (GUIDANCE)

NCT Number: NCT05050084

Phase: III

Protocol Type: Treatment

Age Group: Adult

Disease Sites: Prostate

Study Objectives:

For more information about the trial above please contact the study team:

Principal Investigator, Harriet Eldredge-Hindy, at eldredge@musc.edu.
Study Coordinator, Lydia Moats, at lydia.moats@selfregional.org.
Study Coordinator, Zachary Bargeloh, at bargeloh@musc.edu.

Trial opened at the following institutions: Medical University of South Carolina, Self Regional Medical Center

Study Documents
(MUSC NetID required for document access)